NovaBay Pharmaceuticals Stock (AMEX: NBY)

NovaBay Pharmaceuticals (AMEX:NBY) Stock, Quote.Headers.trade-ideas

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Medicine

News

Movers

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals.

What&#39;s Going On With NovaBay Pharmaceuticals Shares Friday?

vaccine-4892048

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering.

What&#39;s Going On With NovaBay Pharmaceuticals (NBY) Stock?

Earnings

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

COUR

DXCM

NMHI

WINT

S&amp;P 500 Gains Over 1%; 3M Shares Jump After Q2 Results

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals Inc

Niobay Metals Inc

NovaBay Pharmaceuticals, Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to <a href="https://www.benzinga.com/news/24/09/40956105/novabay-pharmaceuticals-reaches-definitive-deal-to-sell-avenova-assets-for-9-5m-expected-to-close-q4">Physician Recommended Nutraceuticals</a>.
The Details: The company expects the transaction to close during the 2024 fourth quarter, pending NovaBay shareholder approval. 
&#8220;I believe we have found an ideal home for Avenova. We expect the brand to continue to grow and flourish under PRN&#8217;s capable leadership and their ability to promote Avenova through their existing network of more than 5,000 eyecare professionals,&#8221; said NovaBay CEO Justin Hall.
&#8220;It&#8217;s gratifying to share that more people are using Avenova than ever before and with the support, resources and synergies that PRN can provide, we expect that number to continue to grow.&#8221;
How To Buy NovaBay Shares
By now you're likely curious about how to participate in the market for NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
mIf you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Related Link: <a href="https://www.benzinga.com/markets/cannabis/24/09/40900626/legal-medical-cannabis-could-save-us-healthcare-29b-annually-new-study-finds">Legal Medical Cannabis Could Save US Healthcare $29B Annually, New Study Finds</a>
NBY Price Action: At the time of writing, NovaBay stock is trading 25.0% higher at 62 cents per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Photo by roberto-sorin for Unsplash

What's Going On With NovaBay Pharmaceuticals Shares Friday?

WIIM

NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.

Asset Sales

NovaBay Pharmaceuticals Reaches Definitive Deal To Sell Avenova Assets For $9.5M, Expected To Close Q4 2024

NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(1.23) by 11.38 percent. This is a 96.92 percent increase over losses of $(44.43) per share from the same period last year. The company reported quarterly sales of $2.40 million which missed the analyst consensus estimate of $3.15 million by 23.81 percent. This is a 32.09 percent decrease over sales of $3.53 million the same period last year.

Earnings Misses

NovaBay Pharmaceuticals Q2 EPS $(1.37) Misses $(1.23) Estimate, Sales $2.40M Miss $3.15M Estimate

NovaBay Pharmaceuticals Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares are lower by 66% to $0.67 over the trailing five sessions after announcing the pricing of its <a href="https://www.benzinga.com/pressreleases/24/07/b39982871/novabay-pharmaceuticals-announces-pricing-of-3-5-million-underwritten-public-offering">public offering</a> of 3.2 million shares (or pre-funded warrants) and Series F-1, F-2, and F-3 warrants.
Each share (or pre-funded warrant) and associated warrants are priced at $1.10. The Series F-1 warrants expire in five years, the F-2 in six months and the F-3 in one year, all with a $1.10 exercise price.
Ladenburg Thalmann &amp; Co. Inc., the underwriter, has a 45-day option to purchase an additional 477,272 shares and/or warrants for over-allotments. Expected gross proceeds are $3.5 million, or $4.0 million if the over-allotment option is fully exercised, before expenses. 
NovaBay plans to use the funds to redeem outstanding debentures and for general corporate purposes. The offering is expected to close around July 29.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40015199/oil-prices-remain-under-pressure-despite-rising-middle-east-tensions-a-bearish-tria">Oil Prices Remain Under Pressure Despite Rising Middle East Tensions: Analyst Says Bearish Price Trend On Horizon</a>
<h1 class="wp-block-heading">Is NBY A Good Stock To Buy?</h1>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages — like <a href="https://www.benzinga.com/quote/NBY">NovaBay Pharmaceuticals</a>&#8216;s page for example — there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. NovaBay Pharmaceuticals does not pay a dividend, but obviously there are a few ways it can return value to shareholders. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 9.16%, you'll need to buy a share of Allspring Inc Opps by Aug. 12, 2024. Once done, you can expect to receive a nominal payout of $0.05 on Sep. 3.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. 
Looking through the latest news on <a href="https://www.benzinga.com/quote/NBY">NovaBay Pharmaceuticals</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NBY has a 52-week high of $44.80 and a 52-week low of $0.64.
Read Next: • <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40016926/markets-brace-for-crucial-interest-rate-shake-up-what-to-expect-from-federal-reserv">Markets Brace For Crucial Interest Rate Shake-Up: What To Expect From Federal Reserve, Bank of Japan, Bank Of England This Week</a>
Photo: Courtesy NBY

What's Going On With NovaBay Pharmaceuticals (NBY) Stock?

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining more than 1% on Friday.
The Dow traded up 1.66% to 40,598.17 while the NASDAQ rose 1.07% to 17,365.04. The S&amp;P 500 also rose, gaining, 1.17% to 5,462.66.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here"> Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a>
Leading and Lagging Sectors Industrials shares jumped by 2% on Wednesday.
In trading on Wednesday, energy shares rose by just 0.6%.
Top Headline
3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) shares jumped around 21% on Friday after the company posted better-than-expected second-quarter financial results and raised its FY24 EPS outlook.
The company reported second-quarter net sales of $6.255 billion, a slight decline of 0.5% year-over-year. Adjusted net sales totaled $6.019 billion, up 1.1% YoY, beating the consensus of $5.878 billion. Adjusted EPS was $1.93, up from $1.39 in the prior-year quarter, beating the consensus of $1.68.
For fiscal 2024, 3M continues to see adjusted total sales growth of (0.25%) to +1.75% and, on an organic basis, flat to +2%. MMM now expects adjusted EPS of $7.00 – $7.30 (prior $6.80 – $7.30) versus the $7.17 consensus.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares shot up 107% to $6.85 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Shares of BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) got a boost, surging 144% to $0.5191 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares were also up, gaining 45% to $10.77 after the company beat second-quarter earnings estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dropped 64% to $0.70 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Shares of DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) were down 42% to $62.50 after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) was down, falling 47% to $0.2087 after the company announced pricing of $1.2 million public offering.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984459/top-3-risk-off-stocks-that-are-set-to-fly-in-july">Top 3 Risk Off Stocks That Are Set To Fly In July</a>
Commodities In commodity news, oil traded down 1.1% to $77.41 while gold traded up 1.2% at $2,381.50.
Silver traded up 0.1% to $28.00 on Friday, while copper fell 0.3% to $4.1145.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.83%, Germany's DAX rose 0.65% and France's CAC 40 rose 1.22%. Spain's IBEX 35 Index rose 0.18%, while London's FTSE 100 rose 1.21%.
Median expectations for inflation over the next 12 months for the Eurozone came in unchanged at 2.8% for June. Spanish unemployment rate declined to 11.27% during the second quarter. The consumer confidence indicator in France climbed to 90.8 in July compared to a revised reading of 89.7 in the prior month.
Asia Pacific Markets
Asian markets closed mostly higher on Friday, with Japan's Nikkei 225 falling 0.53%, Hong Kong's Hang Seng Index gaining 0.1%, China's Shanghai Composite Index gaining 0.14% and India's S&amp;P BSE Sensex jumping 1.62%.
Foreign exchange reserves held by the Reserve Bank of India rose to $670.9 billion as of July 19. The index of coincident economic indicators in Japan rose to 117.1 in May versus a flash reading of 116.5.
Economics
<ul>
<li>The headline Personal Consumption Expenditure (PCE) price index fell to 2.5% year-on-year in June, as expected.</li>
<li>Personal spending in the U.S. rose 0.3% from the prior month in June, while personal income increased by 0.2% to $23.948 trillion in June.</li>
<li>The University of Michigan consumer sentiment was revised higher to 66.4 in July compared to a preliminary level of 66.</li>
<li>The total number of active U.S. oil rigs climbed by 5 to 482 rigs this week, Baker Hughes Inc reported</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a>

S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results

NovaBay Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NASDAQ">NBY</a>) shares are trading lower by 62% to $0.73 during Friday&#8217;s session after the company announced the pricing of its public offering of <a href="https://www.benzinga.com/pressreleases/24/07/b39982871/novabay-pharmaceuticals-announces-pricing-of-3-5-million-underwritten-public-offering">3,200,380 shares of common stock</a> (or pre-funded warrants) along with accompanying Series F-1, F-2, and F-3 warrants.
The combined price for each share (or pre-funded warrant) and associated warrants is $1.10. The Series F-1 warrants expire in five years, the F-2 in six months, and the F-3 in one year, each with an exercise price of $1.10 per share. 
The underwriter, Ladenburg Thalmann &amp; Co. Inc., has a 45-day option to purchase up to an additional 477,272 shares and/or warrants to cover over-allotments. 
The total gross proceeds are expected to be around $3.5 million, or $4.0 million if the over-allotment option is fully exercised, before expenses. NovaBay plans to use the proceeds to redeem outstanding debentures and for general corporate purposes. The offering is set to close around July 29.
Read Also: <a href="https://www.benzinga.com/news/24/07/39986346/why-taiwan-semiconductor-manufacturing-company-shares-are-volatile-this-week">Why Taiwan Semiconductor Manufacturing Company Shares Are Volatile This Week</a>
<h2 class="wp-block-heading">Should I Sell My NBY Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. NovaBay Pharmaceuticals stock currently has an RSI of 25.04, indicating oversold conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
NBY has a 52-week high of $44.80 and a 52-week low of $0.74.

Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%

Shares of Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SAIA/earnings">second-quarter financial results</a>.
Saia reported quarterly earnings of $3.83 per share which missed the analyst consensus estimate of $4.00 per share. The company reported quarterly sales of $823.24 million which missed the analyst consensus estimate of $826.55 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Saia shares dipped 18.6% to $398.01 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 117.4% to $0.4639 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares jumped 101.3% to $6.67 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 53% to $13.94.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares gained 46.2% to $10.83 after the company beat second-quarter earnings estimates.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) shares climbed 43.3% to $8.84. Carbon Revolution said it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1.</li>
<li>Everi Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVRI#NYSE">EVRI</a>) rose 41.1% to $12.93 after it entered an agreement to be acquired by funds managed by Apollo affiliates for $14.25 per share in cash.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 37% to $4.45.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) jumped 36.6% to $8.66 on better-than-expected second-quarter earnings and raising FY24 outlook.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) gained 35% to $0.9043.</li>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) rose 28% to $1.55 after the company announced results from a bias analysis conducted for its concluded Phase 3 study of Multikine. Multikine cut the 5-year risk of death by half compared to control in its target population.</li>
<li>AudioEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) rose 25% to $24.52 following second-quarter results.</li>
<li>Pineapple Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NYSE">PAPL</a>) gained 24.4% to $1.1760. Pineapple Financial CSO Christa Lillian Mitchell bought a total of 2,000 shares at an average price of $0.88.</li>
<li>Douglas Elliman Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) climbed 23% to $1.66.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) rose 19% to $6.71.</li>
<li>Liberty Broadband Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) rose 17.6% to $65.16.</li>
<li>Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) jumped 17% to $368.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>Mohawk Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) gained 16.5% to $156.70 following mixed second-quarter earnings.</li>
<li>Karooooo Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) gained 16% to $33.40. Karooooo announced termination of secondary public offering of ordinary shares due to market conditions.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) climbed 15% to $118.99 after better-than-expected second-quarter financial results and FY24 EPS outlook raise.</li>
<li>International Game Technology PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) gained 13.4% to $22.86 after the company entered an agreement for its Gaming &amp; Digital business to be acquired by funds managed by affiliates of Apollo.</li>
<li>Altice USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) rose 12.1% to $1.76.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) rose 11% to $15.06.</li>
<li>Avantor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) surged 11% to $25.32 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) gained 10.7% to $246.86 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares gained 10.4% to $0.0415 after falling over 17% on Thursday.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) rose 9% to $20.58. Viasat announced new reporting segment structure.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares gained 8.7% to $914.71 as the company reported better-than-expected results for the first quarter. The company said it still expects net sales to increase approximately 10% year-over-year in fiscal year 2025 to $4.7 billion.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) climbed 7.6% to $48.69 following strong second-quarter earnings and increased 2024 guidance.</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) climbed 7.6% to $72.55 following better-than-expected second-quarter financial results and increased 2024 guidance.</li>
<li>Columbia Banking System, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) rose 7.4% to $25.98 after the company reported better-than-expected quarterly earnings results. Also, multiple firms raised their respective price targets on its stock.</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) gained 6.8% to $319.30 after the company reported better-than-expected quarterly revenue results.</li>
<li>Ultra Clean Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) shares gained 4.7% to $47.26 following better-than-expected quarterly results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dipped 59.6% to $0.7830 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) fell 46.9% to $0.2603.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) fell 46.4% to $0.2099 after the company announced pricing of $1.2 million public offering.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 40.7% to $63.97 after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) fell 29.6% to $1.3150. Predictive Oncology announced exercise of warrants for $1.26 million gross proceeds.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) declined 29.2% to $1.5006 as the company reported top-line data from its Phase 1a Alzheimer&#8217;s trial and announced up to $122.7 million private placement financing.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) dipped 26.1% to $1.53</li>
<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) fell 23.8% to $0.2751.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NASDAQ">OPTT</a>) shares declined 23.2% to $0.3188 after reporting fourth-quarter results.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) fell 20.2% to $1.30.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) declined 20.1% to $1.6299.</li>
<li>Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares fell 18.9% to $8.27 after the company reported worse-than-expected second-quarter financial results.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) declined 17.6% to $1.24.</li>
<li>Ur-Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URG#NYSE">URG</a>) shares dipped 13.4% to $1.1250 after the company announced a proposed public offering of common shares.</li>
<li>BJ&#8217;s Restaurants, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>) fell 12.6% to $32.53 following quarterly results.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) declined 11.8% to $135.36 following a first-quarter earnings miss and soft EPS guidance.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADN#NASDAQ">ADN</a>) shares fell 11.2% to $4.40 after gaining 3% on Thursday.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) fell 9.1% to $25.67.</li>
<li>World Acceptance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) dipped 7.8% to $134.62 following weak quarterly sales.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) fell 7.4% to $25.61.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) shares declined 7.2% to $44.56 following a second-quarter earnings miss.</li>
<li>Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) shares fell 6.6% to $55.87 following weak quarterly sales.</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) declined 6.3% to $213.01 after the European Medicines Agency adopted a negative opinion on the Marketing Authorization Approval for lecanemab.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares fell 6% to $38.18. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.</li>
<li>L3Harris Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) declined 4.6% to $232.05 following second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

AEYE

ATUS

AVGR

AVTR

BIIB

BJRI

CHTR

CMAX

COLB

CREV

DECK

DOUG

EVRI

FWRD

GROM

KARO

KITT

LBRDA

Next Technology Holding Inc. - Ordinary Shares

NXTT

OPTT

PAPL

POAI

PSIG

SAIA

SDST

SGMO

SLNA

TANH

TARS

TNDM

TWOU

UCTT

VSAT

WRLD

ZYXI

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

NovaBay Pharmaceuticals shares are trading lower after the company priced a public offering of 3.2M shares and warrants at $1.10 per share.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday.
The Dow traded up 1.60% to 40,574.53 while the NASDAQ rose 0.74% to 17,309.62. The S&amp;P 500 also rose, gaining, 0.99% to 5,452.49.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a>
Leading and Lagging Sectors Industrials shares jumped by 1.7% on Wednesday.
In trading on Wednesday, energy shares fell by 0.3%.
Top Headline
Bristol Myers Squibb &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)  posted strong second-quarter earnings and increased 2024 guidance.
Bristol Myers Squibb posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for foreign exchange impacts, primarily driven by the Growth Portfolio and Eliquis. The company reported an adjusted EPS of $2.07, compared to an income of $1.75 a year ago, beating the consensus of $1.63.
Bristol Myers Squibb revised 2024 adjusted EPS guidance to $0.60-$0.90 versus prior guidance of $0.40-$0.70 and consensus Of $0.51. For 2024, the U.S. drug maker expects revenue growth to be at the upper end of the previously provided low single-digit range.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares shot up 106% to $6.80 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Shares of BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) got a boost, surging 219% to $0.6770 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares were also up, gaining 37% to $10.13 after the company beat second-quarter earnings estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dropped 61% to $0.7718 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Shares of DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) were down 42% to $63.09 after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) was down, falling 48% to $0.2055 after the company announced pricing of $1.2 million public offering.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984459/top-3-risk-off-stocks-that-are-set-to-fly-in-july">Top 3 Risk Off Stocks That Are Set To Fly In July</a> 
Commodities In commodity news, oil traded down 2.4% to $76.44 while gold traded up 1.2% at $2,381.50.
Silver traded down 0.4% to $27.86 on Friday, while copper rose 0.1% to $4.1255.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.85%, Germany's DAX rose 0.67% and France's CAC 40 rose 1.24%. Spain's IBEX 35 Index rose 0.17%, while London's FTSE 100 rose 1.15%.
Median expectations for inflation over the next 12 months for the Eurozone came in unchanged at 2.8% for June. Spanish unemployment rate declined to 11.27% during the second quarter. The consumer confidence indicator in France climbed to 90.8 in July compared to a revised reading of 89.7 in the prior month.
Asia Pacific Markets
Asian markets closed mostly higher on Friday, with Japan's Nikkei 225 falling 0.53%, Hong Kong's Hang Seng Index gaining 0.1%, China's Shanghai Composite Index gaining 0.14% and India's S&amp;P BSE Sensex jumping 1.62%.
Foreign exchange reserves held by the Reserve Bank of India rose to $670.9 billion as of July 19. The index of coincident economic indicators in Japan rose to 117.1 in May versus a flash reading of 116.5.
Economics
<ul>
<li>The headline Personal Consumption Expenditure (PCE) price index fell to 2.5% year-on-year in June, as expected.</li>
<li>Personal spending in the U.S. rose 0.3% from the prior month in June, while personal income increased by 0.2% to $23.948 trillion in June.</li>
<li>The University of Michigan consumer sentiment was revised higher to 66.4 in July compared to a preliminary level of 66.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a> </li>
</ul>

Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 550 points on Friday.
The Dow traded up 1.40% to 40,494.80 while the NASDAQ rose 0.60% to 17,285.07. The S&amp;P 500 also rose, gaining, 0.80% to 5,442.35.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a>
Leading and Lagging Sectors Industrials shares jumped by 1.5% on Wednesday.
In trading on Wednesday, communication services shares rose by just 0.1%.
Top Headline
The headline Personal Consumption Expenditure (PCE) price index fell to 2.5% year-on-year in June, as expected.
The core component remained steady at 2.6%, countering expectations of a drop to 2.5%. The headline index's decline to 2.5% marks the lowest point since February 2021, a level also seen in January and February 2024.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares shot up 136% to $7.78 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Shares of BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) got a boost, surging 58% to $0.3376 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares were also up, gaining 55% to $11.49 after the company beat second-quarter earnings estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dropped 58% to $0.8128 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Shares of Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) were down 53% to $0.2320.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) was down, falling 47% to $0.2070 after the company announced pricing of $1.2 million public offering.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984459/top-3-risk-off-stocks-that-are-set-to-fly-in-july">Top 3 Risk Off Stocks That Are Set To Fly In July</a> 
Commodities In commodity news, oil traded down 1.3% to $77.24 while gold traded up 1.1% at $2,379.20.
Silver traded down 0.4% to $27.855 on Friday, while copper fell 0.1% to $4.1210.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.6%, Germany's DAX rose 0.3% and France's CAC 40 rose 0.9%. Spain's IBEX 35 Index fell 0.3%, while London's FTSE 100 rose 1%.
Median expectations for inflation over the next 12 months for the Eurozone came in unchanged at 2.8% for June. Spanish unemployment rate declined to 11.27% during the second quarter. The consumer confidence indicator in France climbed to 90.8 in July compared to a revised reading of 89.7 in the prior month.
Asia Pacific Markets
Asian markets closed mostly higher on Friday, with Japan's Nikkei 225 falling 0.53%, Hong Kong's Hang Seng Index gaining 0.1%, China's Shanghai Composite Index gaining 0.14% and India's S&amp;P BSE Sensex jumping 1.62%.
Foreign exchange reserves held by the Reserve Bank of India rose to $670.9 billion as of July 19. The index of coincident economic indicators in Japan rose to 117.1 in May versus a flash reading of 116.5.
Economics
<ul>
<li>The headline Personal Consumption Expenditure (PCE) price index fell to 2.5% year-on-year in June, as expected.</li>
<li>Personal spending in the U.S. rose 0.3% from the prior month in June, while personal income increased by 0.2% to $23.948 trillion in June</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a> </li>
</ul>

Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%

NovaBay Pharmaceuticals Prices Public Offering Of 3.2M Shares And Warrants At $1.10 Per Share

Shares of Ultra Clean Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) shares surged 17.4% to $53.00 in pre-market trading following better-than-expected <a href="https://www.benzinga.com/quote/UCTT/earnings">quarterly results</a>.
Ultra Clean reported quarterly earnings of 32 cents per share which beat the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $516.100 million which beat the analyst consensus estimate of $490.064 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Ultra Clean shares jumped 17.4% to $53.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) rose 110.3% to $6.94 in pre-market trading. Windtree Therapeutics filed Form RW to withdraw registration statement on Form S-1.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 83% to $0.39 in pre-market trading after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) shares climbed 30.6% to $8.06 in pre-market trading. Carbon Revolution said it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares gained 24.7% to $9.24 in pre-market trading after the company beat second-quarter earnings estimates.</li>
<li>Zapata Computing Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZPTA#NASDAQ">ZPTA</a>) gained 24.5% to $0.6720 in pre-market trading.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares gained 23.7% to $0.0465 in pre-market trading after falling over 17% on Thursday.</li>
<li>Mohawk Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) gained 11.5% to $150.00 in pre-market trading following mixed second-quarter earnings.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares gained 11.2% to $935.45 in pre-market trading as the company reported better-than-expected results for the first quarter. The company said it still expects net sales to increase approximately 10% year-over-year in fiscal year 2025 to $4.7 billion.</li>
<li>Karooooo Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) gained 9.4% to $31.50 in pre-market trading. Karooooo announced termination of secondary public offering of ordinary shares due to market conditions.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares fell 40.7% to $1.15 in pre-market trading after dipping 10% on Thursday.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 37% to $68.00 in pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADN#NASDAQ">ADN</a>) shares fell 35.2% to $3.21 in pre-market trading after gaining 3% on Thursday.</li>
<li>Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) shares fell 31.2% to $0.2696 in pre-market trading after declining around 9% on Thursday.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NASDAQ">OPTT</a>) shares declined 21.7% to $0.3250 in pre-market trading after reporting fourth-quarter results.</li>
<li>Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares fell 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) fell 16.4% to $0.4181 in pre-market trading after gaining around 25% on Thursday.</li>
<li>Conn&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CONN#NASDAQ">CONN</a>) fell 13.7% to $0.3528 in pre-market trading after surging 17% on Thursday.</li>
<li>Ur-Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URG#NYSE">URG</a>) shares dipped 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares fell 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39978094/s-p-500-nasdaq-settle-lower-as-tech-stocks-continue-to-falter-greed-index-in-fear-zone">S&amp;P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In &#8216;Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

CONN

XCUR

ZPTA

Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Net revenue from the Company&#39;s eyecare products increased by 9% for both the second quarter and the first half of 2024 over the corresponding periods in 2023. NovaBay also expects 2024 net revenue from the Company&#39;s eyecare products to be approximately $10 million.&nbsp;

Guidance

General

Novabay Pharmaceuticals Announces Preliminary Net Revenue For The Second Quarter Of 2024 Of $2.4M Versus Consensus Of $3.15M And For The First Half Of 2024 Of $5M, Primarily Derived From The Company's Eyecare Products

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.novabay.com%2F&amp;esheet=54088904&amp;newsitemid=20240701139750&amp;lan=en-US&amp;anchor=NovaBay%26%23174%3B+Pharmaceuticals%2C+Inc&amp;index=1&amp;md5=1a03d35f8674b56d554e85b30f688abd">NovaBay&reg;&nbsp;Pharmaceuticals, Inc</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>), a company developing and commercializing high-quality eyecare products, and&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Feyenovia.com%2F&amp;esheet=54088904&amp;newsitemid=20240701139750&amp;lan=en-US&amp;anchor=Eyenovia%2C+Inc&amp;index=2&amp;md5=94e84f4d7ed06b08285e0e2c511fa0cd">Eyenovia, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, have commenced activities under a&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.novabay.com%2Fpress-release%3Fi%3D132044&amp;esheet=54088904&amp;newsitemid=20240701139750&amp;lan=en-US&amp;anchor=previously+announced+co-promotion+agreement&amp;index=3&amp;md5=805b32bf4e2cd014d35eabc28fd326c1">previously announced co-promotion agreement</a>.
Under the agreement, Eyenovia is leveraging its ten-person field salesforce to promote NovaBay&#39;s Avenova Antimicrobial Lid &amp; Lash Solution to large ophthalmic surgery centers along with one of Eyenovia&#39;s other FDA-approved products, MydCombi for mydriasis. In parallel, NovaBay has initiated reconnaissance and market preparation activities ahead of Eyenovia&#39;s launch of Clobetasol Propionate Ophthalmic Suspension,&nbsp;0.05%, an innovative, rapid, sustained and more convenient solution for the treatment of postoperative inflammation and pain. Clobetasol is expected to be commercially available in August 2024. NovaBay will conduct outreach through its telephone-based physician dispensed channel to supplement geographic areas not covered by Eyenovia.

EYEN

NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers

NovaBay Pharmaceuticals Announces Warrant Exercise At Reduced Price Of $2.50; 90,381 Shares Exercised, Generating $225,952 In Gross Proceeds

<h3>Gainers</h3>
<ul>
<li>Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) shares rose 24.5% to $36.0 during Wednesday's pre-market session. The company's market cap stands at $3.4 billion. </li>
<li>Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares moved upwards by 18.43% to $5.91. The market value of their outstanding shares is at $196.1 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares increased by 15.84% to $0.95. The company's market cap stands at $6.0 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares increased by 15.74% to $1.25. The market value of their outstanding shares is at $3.3 million. </li>
<li>Oramed Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORMP#NASDAQ">ORMP</a>) stock moved upwards by 14.49% to $2.37. The market value of their outstanding shares is at $96.2 million. </li>
<li>NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) stock rose 12.72% to $3.1. The market value of their outstanding shares is at $3.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ThermoGenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THMO#NASDAQ">THMO</a>) shares decreased by 40.5% to $0.33 during Wednesday's pre-market session. The company's market cap stands at $2.6 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares fell 11.86% to $0.24. The market value of their outstanding shares is at $15.2 million. </li>
<li>Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) shares decreased by 10.94% to $0.57. The market value of their outstanding shares is at $35.4 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares decreased by 8.28% to $0.8. The company's market cap stands at $132.8 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares decreased by 8.11% to $1.7. The market value of their outstanding shares is at $2.4 million. </li>
<li>Bright Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGXX#NASDAQ">BGXX</a>) stock fell 7.91% to $0.28. The market value of their outstanding shares is at $53.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGXX

CLDI

CYCC

LGVN

MOLN

ORMP

STRM

TCON

THMO

TVGN

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

NovaBay Pharmaceuticals Says NYSE Has Accepted The Company's Plan To Regain Compliance With Continued Listing Standards

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 300 points on Thursday.
The Dow traded down 0.83% to 38,122.78 while the NASDAQ fell 0.67% to 16,807.02. The S&amp;P 500 also fell, dropping, 0.36% to 5,247.83.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/05/39084656/how-to-earn-500-a-month-from-nvidia-stock-following-strong-earnings-report">How To Earn $500 A Month From Nvidia Stock Following Strong Earnings Report</a>
Leading and Lagging Sectors Real estate shares rose by 1.3% on Thursday.
In trading on Thursday, information technology shares dipped by 1.3%.
Top Headline
Best Buy Co., Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) reported better-than-expected earnings for its fiscal first quarter.
The company posted adjusted EPS of $1.20, beating the street view of $1.08. Quarterly sales of $8.85 billion missed the analyst consensus of $8.96 billion. The firm approved a regular quarterly dividend of $0.94 per share.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) shares shot up 19% to $26.70 following a first-quarter earnings beat.
Shares of Red Robin Gourmet Burgers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) got a boost, surging 15% to $7.71 following first-quarter results.
OneMedNet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares were also up, gaining 29% to $2.52 after the company announced that it has entered into a non-exclusive three-year Master Services Agreement with an undisclosed U.S.-based medical technology company.
Equities Trading DOWN
Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares dropped 35% to $2.0108 after the company reported worse-than-expected first-quarter financial results and issued FY24 revenue guidance below estimates.
Shares of NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) were down 36% to $0.1041. NovaBay Pharmaceuticals announced plans for a 1-for-35 reverse stock split and revealed the receipt of NYSE American notice regarding stockholders' equity.
UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) was down, falling 34% to $12.09 after the company reported first-quarter earnings, issued weak revenue guidance and announced a CEO transition. Some analysts downgraded the stock following the report.
Also Check This Out: Ji<a href="https://www.benzinga.com/top-stories/24/05/39084892/jim-cramer-doesnt-care-that-nelson-peltz-is-out-of-disney-says-traders-should-avoid-this-real-estate">m Cramer Doesn&#8217;t Care That Nelson Peltz Is Out Of Disney, Says Traders Should Avoid This Real Estate Stock</a>
Commodities In commodity news, oil traded down 1.9% to $77.75 while gold traded up 1% at $2,364.90.
Silver traded down 2.7% to $31.485 on Thursday, while copper fell 2.7% to $4.6630.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.59%, Germany's DAX gained 0.13% and France's CAC 40 gained 0.55%. Spain's IBEX 35 Index jumped 1.73%, while London's FTSE 100 gained 0.59%.
The services sentiment indicator in the Eurozone rose to 6.5 in May from 6.1 in April, while industry confidence indicator climbed to -9.9 in May versus a revised reading of -10.4 in April. Consumer confidence in the Eurozone gained by 0.4 points to -14.3 in May, while economic sentiment indicator surged to 96 points in May, recording the highest level in four months. The unemployment rate in the Eurozone fell to a new record low of 6.4% in April.
Asia Pacific Markets
Asian markets closed lower on Thursday, with Japan's Nikkei falling 1.30%, China's Composite Index dipping 0.62%, Hong Kong's Hang Seng Index falling 1.34% and India's S&amp;P BSE Sensex falling 0.83%.
Economics
<ul>
<li>U.S. wholesale inventories increased by 0.2% month-over-month in April following a 0.4% decline in the previous month and versus market estimates of a 0.1% fall.</li>
<li>The U.S. trade deficit in goods increased to $99.41 billion in April following a revised $92.29 billion gap in the earlier month.</li>
<li>U.S. initial jobless claims increased by 3,000 to 219,000 in the week ending May 25, compared to market estimates of 218,000.</li>
<li>The U.S. economy grew an annualized 1.3% in the first quarter, compared to 3.4% in the prior quarter.</li>
<li>Pending home sales fell by 7.7% month-over-month in April.</li>
<li>The EIA said stocks of crude oil in the U.S. fell by 4.16 million barrels in the week ending May 24 compared to market estimates of a 1.95 million barrels fall.</li>
<li>U.S. natural-gas supplies rose 84 billion cubic feet during the week ended May 24.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/05/39084860/apple-to-rally-around-29-here-are-10-top-analyst-forecasts-for-thursday">Apple To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday</a>

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

ONMD

PATH

RRGB

Gold Gains 1%; Best Buy Posts Upbeat Earnings

Shares of American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) fell during Thursday's session <a href="https://www.benzinga.com/news/earnings/24/05/39074813/american-eagle-outfitters-reports-q1-results-the-details">following first-quarter results</a>.
American Eagle Outfitters reported adjusted earnings of 17 cents per share and quarterly revenue of $1.143 billion, up from $1.08 billion from the same period last year, but below the analyst estimate of $1.15 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
American Eagle Outfitters sees second-quarter operating income in a range of $95 million to $100 million and fiscal-year 2024 operating income in a range of $445 million and $465 million.
American Eagle Outfitters shares fell 4.5% to $22.98 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cue Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) shares jumped 100.7% to $0.11. Cue Health shares dipped around 40% on Wednesday after the company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) shares jumped 57% to $6.14 after gaining around 17% on Wednesday. Smart For Life completed restructuring program, enhancing financial stability.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) rose 51% to $0.6735. Faraday Future Intelligent Electric recently reported worse-than-expected fiscal year 2023 sales results and withdrew its production target guidance. The company also received a written notice from Nasdaq regarding its failure to timely file the Quarterly Report on Form 10-Q, further impacting investor confidence.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) gained 61% to $53.35.</li>
<li>OneMedNet Corporation. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares climbed 41.5% to $2.7650 after the company announced that it has entered into a non-exclusive three-year Master Services Agreement with an undisclosed U.S.-based medical technology company.</li>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) gained 33% to $3.6931</li>
<li>Kintara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares rose 26% to $0.3421 after jumping around 45% on Wednesday.&nbsp;</li>
<li>Phoenix New Media Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) jumped 26% to $2.2781.</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) gained 25.9% to $28.35 following a first-quarter earnings beat.</li>
<li>American Superconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares jumped 25.4% to $19.79 following strong quarterly earnings.</li>
<li>Red Robin Gourmet Burgers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) jumped 22% to $8.21 following first-quarter results.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) gained 21.8% to $0.3682.</li>
<li>Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) rose 19.2% to $238.93 following better-than-expected first-quarter earnings.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 18.4% to $3.7088.</li>
<li>Claros Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>) rose 16.1% to $8.11.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) climbed 16% to $8.95.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) climbed 15.1% to $19.57.</li>
<li>Nexalin Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) shares climbed 15% to $0.7650 after dipping 29% on Wednesday.</li>
<li>Alignment Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) gained 12.6% to $7.86 after Baird initiated coverage on the stock with an Outperform rating and $10 price target.</li>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) rose 12.5% to $36.94 following better-than-expected second-quarter financial results.</li>
<li>C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) gained 12.2% to $26.89 following strong fourth-quarter earnings.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) gained 12.5% to $22.76 following upbeat earnings.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 11.5% to $15.98</li>
<li>Birkenstock Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) rose 10.5% to $55.26 after the company reported strong second-quarter earnings and raised its full-year revenue growth guidance.</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) gained 9% to $78.37 following first-quarter earnings.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) rose 5.4% to $65.88.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares fell 38% to $1.9276 after the company reported worse-than-expected first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) dipped 35% to $0.49</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) fell 34.8% to $11.94 after the company reported first-quarter earnings, issued weak revenue guidance and announced a CEO transition. Some analysts downgraded the stock following the report.</li>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) fell 30.7% to $0.1130. NovaBay Pharmaceuticals announced plans for a 1-for-35 reverse stock split and revealed the receipt of NYSE American notice regarding stockholders' equity.</li>
<li>flyExclusive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYX#NASDAQ">FLYX</a>) dipped 29.4% to $5.76.</li>
<li>Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) declined 27% to $19.89 following worse-than-expected quarterly financial results.</li>
<li>Tungray Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) fell 23.7% to $2.86.</li>
<li>Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) shares fell 20.1% to $216.95. Salesforce reported upbeat earnings for the first quarter, while sales missed estimates. The company issued weak guidance for the second quarter.</li>
<li>Noah Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) declined 19.4% to $10.88 after the company reported first-quarter earnings. JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $18 to $13.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNOA#NASDAQ">SNOA</a>) shares fell 18.1% to $0.2124 after gaining over 28% on Wednesday.</li>
<li>Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) fell 17.7% to $60.33 after reporting quarterly earnings.</li>
<li>Hywin Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NASDAQ">HYW</a>) dipped 17.6% to $0.3461. Hywin Holdings announced receipt of notification from the Nasdaq.</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares fell 17.2% to $2.1819. BEN shares surged around 108% on Wednesday after the company announced a $4.95 million private placement and appointed Paul Chang to Co-CEO.</li>
<li>Build-A-Bear Workshop, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) declined 14.1% to $27.49 following worse-than-expected first-quarter financial results.</li>
<li>LightInTheBox Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) fell 12% to $0.55.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) declined 7.2% to $28.08.</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) fell 7% to $49.43.</li>
<li>Abercrombie &amp; Fitch Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) declined 6.5% to $177.11. Abercrombie &amp; Fitch posted better-than-expected first-quarter financial results and raised guidance on Wednesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/top-stories/24/05/39088775/nvidia-ge-healthcare-technologies-and-a-video-streaming-giant-on-cnbcs-final-trades">Nvidia, GE HealthCare Technologies And A Video Streaming Giant On CNBC&#8217;s &#8216;Final Trades</a>&#8216;

ALHC

AMSC

BIRK

BNAI

BURL

CFLT

CMTG

CRDO

FENG

FFIE

FLYX

FTEL

GTLB

HLTH

HUMA

Kintara Therapeutics, Inc. - Common Stock

KTRA

LITB

NOAH

NTNX

SERV

SMFL

SNOA

SOBR

TRSG

WBUY

WOOF

Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

NovaBay Pharma (NBY) just unveiled an announcement. This report includes forward-looking statements that predict the company's strategic business p...

NovaBay Pharma Outlines Strategic Future Projections

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

NovaBay Pharmaceuticals announces pricing of $3.5M underwritten offering

NovaBay Q2 2024 Earnings Preview

Here's the major earnings after the close today

NovaBay GAAP EPS of -$1.37 misses by $0.14, revenue of $2.4M misses by $0.75M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) just reported results for the second quarter of 2024.<ul><li>NovaBay Pharmaceuticals reported earnings per share of -$1.37. This was below the analyst estimate for EPS of -$1.23.</li><li>The company reported revenue of $2.40 million.</li><li>This was 23.81% worse than the analyst estimate for revenue of $3.15 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/nby-stock-earnings-novabay-pharmaceuticals-for-q2-of-2024/">NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript

NovaBay Pharmaceuticals to sell Avenova assets for $9.5M

The latest update is out from NovaBay Pharma ( ($NBY) ). NovaBay Pharmaceuticals, Inc. has signed an agreement to sell the Avenova eyecare product ...

NovaBay Pharma Announces Avenova Sale and Planned Dissolution

ACHV

ARMN

ASXC

BEEM

BLMZ

CTSO

CURI

DPRO

DRRX

FLUT

GROY

HIVE

IMOS

KNTNF

LAAC

LGMK

MRCY

NVVE

NWHUF

OUST

QFIN

QUIK

REED

RENB

RKDA

SHWZ

VTGN

WPRT

ZVRA

Press Releases

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.'s Avenova Brand and Business Is Fair to Shareholders

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals (NBY) Forecast

NovaBay Pharmaceuticals (AMEX:NBY) Stock, Quote.Headers.trade-ideas